SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-24-019506
Filing Date
2024-04-12
Accepted
2024-04-12 07:18:26
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-12

Document Format Files

Seq Description Document Type Size
1 ARS ny20024347x3_ars.pdf ARS 1498685
  Complete submission text file 0001140361-24-019506.txt   2065572
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40366 | Film No.: 24839970
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)